Pharma companies are getting more and more open about their digital health initiatives, which has given MobiHealthNews more opportunities this quarter than usual to chronicle pharma’s efforts around ...

“Our partnership with CRIO accelerates our strategy connecting site-level eSource and the Medidata Platform,” said Tom Doyle, chief technology officer, Medidata. “This will accelerate workflows for ...

Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy Again (MAHA) agenda. DHTs are health care focused ...

Public-private collaboration and structured evidence consolidation are emerging as critical enablers of regulatory-ready digital endpoints, helping standardize terminology, reduce duplication, and ...

Cambridge, Massachusetts-based Clinical Research IO, which developed an electronic platform for researchers to quickly capture data during clinical trials, has raised $1.6 million in seed funding in a ...

Throughout the course of a clinical trial, sponsors need to collect strong, repeatable data in order to demonstrate the efficacy and safety of a drug. In trials that rely on patients to take drugs ...

Ruthie Davi, vice president of statistics and regulatory innovation at Medidata, highlights the value of technology in rare ...

In today's ACT Brief, we explore how Bayesian approaches are powering studies in rare disease and pediatrics, a major public-private initiative is standardizing digital endpoints for regulatory ...

Virtual clinical trials and digital twins are emerging approaches to understanding mechanisms of drug responses and drug treatment heterogeneity. With the goal of providing the right drug at the right ...

Research found just 4% of trials over the past decade allowed the inclusion of pregnant women.

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...